Relmada Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. 

CEO
Sergio Traversa
CEOSergio Traversa
Employees
20
Employees20
Headquarters
Coral Gables, Florida
HeadquartersCoral Gables, Florida
Founded
2012
Founded2012
Employees
20
Employees20

RLMD Key Statistics

Market cap
129.15M
Market cap129.15M
Price-Earnings ratio
-1.31
Price-Earnings ratio-1.31
Dividend yield
—
Dividend yield—
Average volume
100.78K
Average volume100.78K
High today
$4.72
High today$4.72
Low today
$4.27
Low today$4.27
Open price
$4.58
Open price$4.58
Volume
86.18K
Volume86.18K
52 Week high
$7.22
52 Week high$7.22
52 Week low
$2.36
52 Week low$2.36
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.